In this review:
AI-assisted communication prior to radical prostatectomy
Real-world outcomes of Lu177 vipivotide tetraxetan in prostate cancer
Clonal cytopenias with radium-223/Lu177
QLC5508 (an ADC targeting B7-H3) in mCRPC
ProTACT: [225Ac]Ac-FL-020 in advanced PSMA-positive mCRPC
Biomarkers of response to bipolar androgen therapy in mCRPC
Xaluritamig + abiraterone acetate in mCRPC
Frailty & survival in prostate cancer
Correlates of undetectable PSA in mHSPC
Prostate cancer risk with ADT & statins after radical prostatectomy
Please login below to download this issue (PDF)